Outcome Measures in Cardiopulmonary Physical Therapy: Focus on the Glittre ADL-Test for People with Chronic Obstructive Pulmonary Disease.
作者信息
Dechman Gail, Scherer Susan A
机构信息
School of Physiotherapy, Dalhousie University, Halifax, NS.
出版信息
Cardiopulm Phys Ther J. 2008 Dec;19(4):115-8.
Abstract
摘要
相似文献
1
Outcome Measures in Cardiopulmonary Physical Therapy: Focus on the Glittre ADL-Test for People with Chronic Obstructive Pulmonary Disease.
Cardiopulm Phys Ther J. 2008 Dec;19(4):115-8.
2
The minimal important difference for Glittre-ADL test in patients with chronic obstructive pulmonary disease.
Braz J Phys Ther. 2020 Jan-Feb;24(1):54-60. doi: 10.1016/j.bjpt.2018.11.009. Epub 2018 Nov 20.
3
Physiological Requirements to Perform the Glittre Activities of Daily Living Test by Subjects With Mild-to-Severe COPD.
Respir Care. 2017 Aug;62(8):1049-1057. doi: 10.4187/respcare.05113. Epub 2017 May 30.
4
The Glittre ADL-Test Differentiates COPD Patients with and without Self-Reported Functional Limitation.
COPD. 2020 Apr;17(2):143-149. doi: 10.1080/15412555.2020.1716707. Epub 2020 Jan 31.
5
Cardiac, ventilatory, and metabolic adjustments in chronic obstructive pulmonary disease patients during the performance of Glittre activities of daily living test.
Chron Respir Dis. 2014 Nov;11(4):247-55. doi: 10.1177/1479972314552805. Epub 2014 Oct 14.
6
Can the Glittre ADL test differentiate the functional capacity of COPD patients from that of healthy subjects?
Rev Bras Fisioter. 2011 Nov-Dec;15(6):467-73. doi: 10.1590/s1413-35552011005000034. Epub 2011 Nov 21.
7
Can a physical activity similar to activities of daily living cause dynamic hyperinflation and change the thoracoabdominal configuration in patients with chronic obstructive pulmonary disease?
Int J Chron Obstruct Pulmon Dis. 2019 Jun 13;14:1281-1287. doi: 10.2147/COPD.S196223. eCollection 2019.
8
Cardiorespiratory Responses to Glittre ADL Test in Bronchiectasis: A Cross-Sectional Study.
Can Respir J. 2018 Dec 17;2018:7470387. doi: 10.1155/2018/7470387. eCollection 2018.
9
Validation and reproducibility of the Glittre activities of daily living test for individuals with Parkinson's disease.
Rev Neurol. 2019 Nov 16;69(10):395-401. doi: 10.33588/rn.6910.2019217.
10
Evaluation of the Glittre-ADL test as an instrument for classifying functional capacity of individuals with cardiovascular diseases.
Braz J Phys Ther. 2017 Sep-Oct;21(5):321-328. doi: 10.1016/j.bjpt.2017.06.001. Epub 2017 Jul 3.
引用本文的文献
1
Prediction of Abnormal Functional Performance in Chronic Obstructive Pulmonary Disease Using Respiratory Models: A Pilot Study.
Int J Chron Obstruct Pulmon Dis. 2025 Aug 22;20:2945-2965. doi: 10.2147/COPD.S524591. eCollection 2025.
2
Respiratory Oscillometry in Chronic Obstructive Pulmonary Disease: Association with Functional Capacity as Evaluated by Adl Glittre Test and Hand Grip Strength Test.
Int J Chron Obstruct Pulmon Dis. 2022 May 4;17:1017-1030. doi: 10.2147/COPD.S353912. eCollection 2022.
3
Normative Values for Londrina ADL Protocol in Healthy Individuals in Age Group of 40-60 Years among Indian Population: A Cross-Sectional Study.
Can Respir J. 2020 Feb 18;2020:8612928. doi: 10.1155/2020/8612928. eCollection 2020.
4
Cardiorespiratory Responses to Glittre ADL Test in Bronchiectasis: A Cross-Sectional Study.
Can Respir J. 2018 Dec 17;2018:7470387. doi: 10.1155/2018/7470387. eCollection 2018.
5
The minimal important difference for Glittre-ADL test in patients with chronic obstructive pulmonary disease.
Braz J Phys Ther. 2020 Jan-Feb;24(1):54-60. doi: 10.1016/j.bjpt.2018.11.009. Epub 2018 Nov 20.
6
Evaluation of the Glittre-ADL test as an instrument for classifying functional capacity of individuals with cardiovascular diseases.
Braz J Phys Ther. 2017 Sep-Oct;21(5):321-328. doi: 10.1016/j.bjpt.2017.06.001. Epub 2017 Jul 3.
7
Validity and Reproducibility of the Glittre ADL-Test in Obese and Post-Bariatric Surgery Patients.
Obes Surg. 2017 Jan;27(1):110-114. doi: 10.1007/s11695-016-2244-7.
8
Incremental shuttle walk test: Reference values and predictive equation for healthy Indian adults.
Lung India. 2016 Jan-Feb;33(1):36-41. doi: 10.4103/0970-2113.173056.
9
Impact of bronchodilator therapy on exercise tolerance in COPD.
Int J Chron Obstruct Pulmon Dis. 2010 Apr 7;5:57-71. doi: 10.2147/copd.s7404.
本文引用的文献
1
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55. doi: 10.1164/rccm.200703-456SO. Epub 2007 May 16.
2
Sex differences in severe pulmonary emphysema.
Am J Respir Crit Care Med. 2007 Aug 1;176(3):243-52. doi: 10.1164/rccm.200606-828OC. Epub 2007 Apr 12.
3
A field test of functional status as performance of activities of daily living in COPD patients.
Respir Med. 2006 Feb;100(2):316-23. doi: 10.1016/j.rmed.2005.04.022. Epub 2005 Jun 6.
4
Gender differences in the management and experience of Chronic Obstructive Pulmonary Disease.
Respir Med. 2004 Dec;98(12):1207-13. doi: 10.1016/j.rmed.2004.05.004.
5
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.
N Engl J Med. 2003 May 22;348(21):2059-73. doi: 10.1056/NEJMoa030287. Epub 2003 May 20.
6
Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length.
Am J Respir Crit Care Med. 2003 Jun 1;167(11):1522-7. doi: 10.1164/rccm.200203-166OC. Epub 2003 Feb 20.
7
ATS statement: guidelines for the six-minute walk test.
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102.
8
A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain.
Chest. 2001 Jan;119(1):256-70. doi: 10.1378/chest.119.1.256.
9
Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL).
Respir Med. 2000 Jun;94(6):589-96. doi: 10.1053/rmed.2000.0786.
10
Development and testing of the modified version of the pulmonary functional status and dyspnea questionnaire (PFSDQ-M).
Heart Lung. 1998 May-Jun;27(3):159-68. doi: 10.1016/s0147-9563(98)90003-6.
Zotero 插件